CALCATERRA, ILENIA LORENZA
 Distribuzione geografica
Continente #
NA - Nord America 620
EU - Europa 270
AS - Asia 176
AF - Africa 11
SA - Sud America 3
OC - Oceania 1
Totale 1.081
Nazione #
US - Stati Uniti d'America 613
IT - Italia 185
SG - Singapore 128
IN - India 23
CN - Cina 22
NL - Olanda 16
DE - Germania 14
UA - Ucraina 13
CI - Costa d'Avorio 11
GB - Regno Unito 11
CA - Canada 7
FI - Finlandia 6
FR - Francia 5
IE - Irlanda 5
CH - Svizzera 4
GR - Grecia 4
AT - Austria 2
CO - Colombia 2
CZ - Repubblica Ceca 2
AU - Australia 1
DK - Danimarca 1
HK - Hong Kong 1
HR - Croazia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 1.081
Città #
Chandler 114
Singapore 109
Ashburn 81
Naples 43
Boardman 42
Millbury 37
Lawrence 29
Des Moines 23
Santa Clara 18
Amsterdam 15
Napoli 14
Boston 10
Castel Volturno 9
Washington 9
Pune 8
Milan 7
Wilmington 7
Seattle 6
Beijing 5
Formia 5
Helsinki 5
Marsala 5
Woodbridge 5
Ercolano 4
Ottawa 4
Zurich 4
Cologno Al Serio 3
Dallas 3
Fairfield 3
Monte San Savino 3
Munich 3
Palermo 3
Abidjan 2
Alcamo 2
Casamassima 2
Delhi 2
Dublin 2
Houston 2
Los Angeles 2
Medellín 2
Nanjing 2
Procida 2
Rome 2
Rovigo 2
Sciacca 2
Torre Del Greco 2
Torre del Greco 2
Brno 1
Callao 1
Caravaggio 1
Casavatore 1
Castellammare Di Stabia 1
Cava de' Tirreni 1
Freiburg im Breisgau 1
Gunzenhausen 1
Hangzhou 1
Hefei 1
Hong Kong 1
Istanbul 1
Košice 1
Kronberg 1
Leawood 1
Marseille 1
Nuremberg 1
Pozzuoli 1
Princeton 1
Santa Maria Capua Vetere 1
Shanghai 1
Taipei 1
Trescore Balneario 1
Urgnano 1
Verona 1
Volos 1
Xi'an 1
Zagreb 1
Ålborg 1
Totale 695
Nome #
An untargeted lipidomic analysis reveals depletion of several phospholipid classes in patients with familial hypercholesterolemia on treatment with evolocumab 54
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 51
Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia 48
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials 41
Lipoprotein(A) where do we stand? from the physiopathology to innovative terapy 40
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 39
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 38
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies 36
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 36
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 35
Clinical assessment of endothelial function in heart failure with preserved ejection fraction: A meta-analysis with meta-regressions 34
Carotid Atherosclerosis, Ultrasound and Lipoproteins 33
Authors’ response to letter by Sbrana et al. “Evolocumab improve intima media thickness regression in He-FH subjects on lipoprotein apheresis” 33
Post-Bariatric Hypoglycemia Is Associated with Endothelial Dysfunction and Increased Oxidative Stress 32
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 31
Association of apolipoprotein levels with peripheral arterial disease: a meta-analysis of literature studies 31
EVOLOCUMAB IS EFFECTIVE AND SAFE TO TREAT HYPERCHOLESTEROLEMIA IN A PATIENT WITH STATIN-INDUCED NECROTIZING MYOPATHY 30
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 30
Association of systemic lupus erythematosus with peripheral arterial disease: a meta-analysis of literature studies 29
Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions 29
Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis 26
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 25
Clinical assessment of endothelial function in convalescent covid-19 patients undergoing multidisciplinary pulmonary rehabilitation 25
Treatment with pcsk9 inhibitors in patients with familial hypercholesterolemia lowers plasma levels of platelet-activating factor and its precursors: A combined metabolomic and lipidomic approach 25
Vascular effects of the polyphenolic nutraceutical supplement taurisolo®: Focus on the protection of the endothelial function 25
Persistent endothelial dysfunction in post-acute covid-19 syndrome: A case-control study 24
Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: A systematic review with meta-analysis.: VTE recurrence and D-dimer 24
Risk assessment and antithrombotic strategies in antiphospholipid antibody carriers 23
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 22
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 18
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 15
Evidence of subclinical atherosclerosis in eosinophilic granulomatosis with polyangiitis 14
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies 14
Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials 14
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 14
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies 14
Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target 13
SHORT-TERM VARIABILITY OF 24-H SYSTOLIC BLOOD PRESSURE IS ASSOCIATED WITH MICROALBUMINURIA IN PATIENTS WITH PRIMARY HYPERTENSION 12
Alirocumab in high cardiovascular risk patients with Heterozygous Familial Hypercholesterolemia: Efficacy and safety in lipid lowering levels 12
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 11
Relationship Between Short-Term Blood Pressure Variability and Subclinical Renal Damage in Essential Hypertensive Patients 10
Average real variability of 24-h systolic blood pressure is associated with microalbuminuria in patients with primary hypertension 8
Metabolic syndrome in hypertensive patients: An unholy alliance 6
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model 4
Intensive FVIII replacement in haemophilia patients with hypertrophic synovium: a randomized study 3
Homozygous Familial Hypercholesterolemia in Campania 3
Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease 3
null 2
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art 2
Totale 1.141
Categoria #
all - tutte 6.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 5 2 4 0 1 0 6 4
2020/202152 2 0 8 1 8 4 2 1 3 1 16 6
2021/2022231 0 7 7 0 11 11 1 7 3 22 92 70
2022/2023267 30 19 11 8 39 33 3 40 38 17 18 11
2023/2024306 22 35 19 19 18 65 3 22 2 6 28 67
2024/2025243 58 54 37 69 25 0 0 0 0 0 0 0
Totale 1.141